Sayona Mining Limited

SYA

Sayona Mining Ltd. engages in sourcing and developing raw materials required for constructing lithium-ion batteries. The company is headquartered in Brisbane, Queensland. The company went IPO on 2004-03-30. The firm's projects include Authier Lithium Project, Tansim Lithium Project, Moblan Lithium Project, Lac Albert Lithium Project, Western Australia Lithium Projects, Western Australia Gold Projects, and Western Australia Graphite Projects. The Authier Lithium project is situated approximately 45 kilometers (km) northwest of the city of Val d'Or, a mining service center in Quebec. The project area comprises 19 mineral claims totaling 653 hectares and extends approximately 3.4 km in the east-west, and 3.1 km in a north-south direction, respectively. The Tansim Lithium project is situated approximately 82 km southwest of the Authier Lithium Project. The project comprises 355 mineral claims spanning 20,546 hectares (ha) and is prospective for lithium, tantalum, and beryllium. The Moblan Lithium project is located in the Eeyou-Istchee James Bay region of northern Quebec.

Global X Battery Tech & Lithium ETF

ACDC

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

Actinogen Medical Limited

ACW

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.

Apollo Minerals Limited

AON

Apollo Minerals Ltd. engages in the mineral exploration and development of Couflens and Aurenere projects. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-10-31. The Salanie Gold Project is located 16 kilometers (km) from the town of Lambarene, and less than two km from the sealed N1 highway and lies within the Company’s 100% owned Keri Permit (G4-456). The Belgrade Copper Project consists of four licenses covering 202 square kilometers (km2), which formed part of the Serbian copper exploration project portfolio. The Kroussou project is located in south-west Gabon on the central west African coast. The project exploration permits, 100% owned by the Company, is approximately 220 km south of the capital Libreville within the Ngounie Province.

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.